Microsoft now prepares to explore new avenues in health care industry with its announcement to acquire Rosetta Biosoftware, a unit of Merck & Co. The company develops software for analyzing genomes and conducting clinical studies. Microsoft plans to administer Rosetta’s assets into its health industry research management software platform - Amalga Life Sciences. Amalga was [...]
Please fill in the following fields
* - Required
Your Name: *
Your E-Mail: *
Your Remarks:
Friend's Name: *
Friend's E-Mail: *
